Occidental Asset Management LLC Buys New Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Occidental Asset Management LLC purchased a new position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) in the 4th quarter, HoldingsChannel reports. The firm purchased 567 shares of the medical equipment provider’s stock, valued at approximately $296,000.

Several other hedge funds have also recently added to or reduced their stakes in the company. Godsey & Gibb Inc. lifted its stake in shares of Intuitive Surgical by 140.0% in the 3rd quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider’s stock valued at $29,000 after purchasing an additional 35 shares during the period. MidAtlantic Capital Management Inc. bought a new stake in Intuitive Surgical in the third quarter worth approximately $33,000. Capital Performance Advisors LLP acquired a new position in Intuitive Surgical in the third quarter valued at approximately $38,000. DT Investment Partners LLC boosted its holdings in shares of Intuitive Surgical by 80.0% during the 3rd quarter. DT Investment Partners LLC now owns 81 shares of the medical equipment provider’s stock worth $40,000 after buying an additional 36 shares in the last quarter. Finally, RPg Family Wealth Advisory LLC acquired a new stake in shares of Intuitive Surgical during the 3rd quarter worth approximately $44,000. Institutional investors own 83.64% of the company’s stock.

Intuitive Surgical Price Performance

Shares of ISRG stock opened at $592.64 on Friday. The firm has a 50-day moving average of $539.54 and a 200-day moving average of $497.69. Intuitive Surgical, Inc. has a one year low of $362.14 and a one year high of $597.68. The company has a market cap of $211.09 billion, a P/E ratio of 95.28, a P/E/G ratio of 4.66 and a beta of 1.39.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings data on Thursday, October 17th. The medical equipment provider reported $1.56 EPS for the quarter, beating the consensus estimate of $1.24 by $0.32. Intuitive Surgical had a net margin of 28.51% and a return on equity of 13.41%. The firm had revenue of $2.04 billion during the quarter, compared to analyst estimates of $2.01 billion. As a group, research analysts expect that Intuitive Surgical, Inc. will post 5.45 earnings per share for the current fiscal year.

Insider Activity

In other Intuitive Surgical news, EVP Brian Edward Miller sold 2,553 shares of the business’s stock in a transaction on Tuesday, October 22nd. The stock was sold at an average price of $515.00, for a total value of $1,314,795.00. Following the sale, the executive vice president now directly owns 7,066 shares in the company, valued at $3,638,990. The trade was a 26.54 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, CFO Jamie Samath sold 108 shares of the company’s stock in a transaction dated Tuesday, November 26th. The shares were sold at an average price of $542.06, for a total transaction of $58,542.48. Following the sale, the chief financial officer now directly owns 8,757 shares in the company, valued at approximately $4,746,819.42. This trade represents a 1.22 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 48,190 shares of company stock valued at $25,012,927 over the last three months. Corporate insiders own 0.90% of the company’s stock.

Wall Street Analyst Weigh In

A number of research analysts recently issued reports on ISRG shares. Wells Fargo & Company boosted their target price on shares of Intuitive Surgical from $549.00 to $630.00 and gave the company an “overweight” rating in a research report on Wednesday, December 11th. Evercore ISI reissued a “cautious” rating on shares of Intuitive Surgical in a research report on Friday, October 18th. Royal Bank of Canada raised their target price on Intuitive Surgical from $525.00 to $555.00 and gave the company an “outperform” rating in a research note on Friday, October 18th. Oppenheimer reaffirmed a “market perform” rating on shares of Intuitive Surgical in a research note on Friday, October 18th. Finally, The Goldman Sachs Group set a $604.00 price objective on Intuitive Surgical in a research note on Friday, October 18th. One investment analyst has rated the stock with a sell rating, four have assigned a hold rating and fifteen have assigned a buy rating to the company. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average price target of $554.17.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.